Valuation (88%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.57 | N/A |
| PEG Ratio (TTM) | 3.58 | N/A |
| P/S Ratio (TTM) | 0.35 | N/A |
| P/B Ratio (TTM) | 1.24 | N/A |
| P/FCF Ratio (TTM) | 6.97 | N/A |
| Price to 5YR AVG Earnings Ratio | 9.61 | N/A |
| Price to 5YR AVG FCF Ratio | 6.69 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.45% | N/A |
| ROE (TTM) | 18.46% | N/A |
| Net Profit Margin (TTM) | 3.97% | N/A |
| ROIC 5YR AVG | 9.49% | N/A |
Growth (87%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 13.68% | 41.84% | 24.39% |
| Revenue | 1.47% | 6.97% | 5.64% |
| Net Income | 14.31% | 43.33% | 24.53% |
| Cash Flow | 99.81% | 20.01% | 27.08% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.13 | N/A |
| Quick Ratio (TTM) | 1.13 | N/A |
| D/E Ratio (TTM) | 1.65 | N/A |
| Interest Coverage (TTM) | 3.12 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 1.58 | N/A |
| LTL to 5YR AVG FCF | 12.55 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.10% | N/A |